antiplatelet treatment

An increase in clopidogrel prescriptions could be seen in the US and Europe for secondary ischaemic stroke prevention as a result of the outcomes of the Phase III POINT trial, according to data and analytics company, GlobalData. Read more


A recent study, published in The Lancet, has recommended that patients over the age of 75, receiving aspirin-based antiplatelet treatment, be co-prescribed proton-pump inhibitors (PPIs) to reduce the incidence of upper gastrointestinal bleeding. Read more